Related Experiment Video

Updated: May 3, 2026

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

12.5K

Listeria monocytogenes: a promising vehicle for neonatal vaccination

Zach Z Liang1, Ashley M Sherrid1, Anu Wallecha2

  • 1Division of Infectious and Immunological Diseases; Department of Pediatrics; University of British Columbia; Child and Family Research Institute; Vancouver, BC Canada.

Human Vaccines & Immunotherapeutics
|February 12, 2014
PubMed

Insights

Developing vaccines for newborns is challenging due to their immature immune systems. Listeria monocytogenes (Lm) shows promise as a safe and effective delivery platform for early-life vaccines.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Childhood infectious diseases pose significant risks, with newborns and infants being particularly vulnerable.
  • Current vaccines offer limited protection for the youngest age groups due to the challenges of the neonatal immune system and safety requirements.

Purpose of the Study:

  • To review the potential of Listeria monocytogenes (Lm) as a vaccine delivery platform for neonatal and early-life immunization.
  • To discuss the properties of Lm that make it suitable for this purpose and identify potential limitations.

Main Methods:

  • Review of existing literature on neonatal immunity, vaccine responses, and the use of Lm as a delivery vehicle.
  • Analysis of the characteristics of Lm relevant to vaccine development for infants.

Main Results:

  • Advances in understanding neonatal immunity suggest that effective early-life vaccination is achievable.
  • Listeria monocytogenes (Lm) possesses key properties making it a promising candidate for neonatal vaccine delivery.

Conclusions:

  • Neonatal vaccination is a feasible goal with ongoing research and technological advancements.
  • Listeria monocytogenes (Lm) represents a promising platform for developing vaccines for newborns and infants, though constraints need consideration.

Keywords:
Listeria monocytogenesadjuvantantigen deliveryattenuationbirthneonatesafetyvaccination

More Related Videos

Measuring Bacterial Load and Immune Responses in Mice Infected with Listeria monocytogenes12:50

Measuring Bacterial Load and Immune Responses in Mice Infected with Listeria monocytogenes

Published on: August 9, 2011

31.6K
Listeria monocytogenes Infection of the Brain05:02

Listeria monocytogenes Infection of the Brain

Published on: October 2, 2018

12.3K

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccinations01:51

Vaccinations

Overview
44.1K
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24